CURX Curanex Pharmaceuticals Inc - Common Stock
$0,30
Prezzo · Mag 20, 2026
Fondamentali al Mag 14, 2026
Intervallo 52 sett.
$0–$9
0% of range
Rating Analisti
—
Prezzo Obiettivo
—
P/E (TTM)
-1.9
ROE
-73.3%
Margine di Profitto Netto
—
CURX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.30
Capitalizzazione di Mercato
$9M
P/E (TTM)
-1.9
EPS (TTM)
$-0.17
Ricavi (TTM)
—
Rendimento div.
—
ROE
-73.3%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$0 – $9
CURX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
EPS
$-0.17
2024-12-31
→
2025-12-31
Flusso di cassa libero
—
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
CURX
Mediana dei peer
P/E (TTM)
-1.9
42.1
P/B
0.8
1.4
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
CURX
Mediana dei peer
ROA
-69.8%
-123.4%
ROE
-73.3%
-108.3%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
CURX
Mediana dei peer
Current Ratio (Rapporto corrente)
81.9
3.7
Quick Ratio
36.5
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
CURX
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
CURX
Mediana dei peer
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CURX | $9M | -1.9 | — | — | -73.3% | — |
| HOTH | $15M | -1.1 | — | — | -156.9% | — |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| BFRI | — | — | — | — | — | — |
| CALC | — | -3.3 | -29.7% | — | — | — |
| SNES | $11M | -1.1 | 19.6% | -287.4% | -77.2% | 62.5% |
| ENVB | $4M | -0.1 | -94.1% | 8275459.4% | -275.8% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 10
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $3M | · | |
| SG&A Expense | $1M | $290.4K | |
| Operating Expenses | $4M | $365.1K | |
| Operating Income | $-4M | $-365.1K | |
| Net Income | $-4M | $-361.5K | |
| EPS (Basic) | $-0.17 | $-0.03 | |
| EPS (Diluted) | $-0.17 | $-0.03 | |
| Shares (Basic) | 25,497,328 | 13,259,016 | |
| Shares (Diluted) | 25,497,328 | 13,259,016 | |
| EBITDA | $-4M | · |
Stato Patrimoniale 15
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $5M | $148.9K | |
| Prepaid Expense | $6M | $1.2K | |
| Other Current Assets | · | $367.9K | |
| Current Assets | $11M | $517.9K | |
| Total Assets | $12M | $517.9K | |
| Accounts Payable | $2.4K | $5.0K | |
| Accrued Liabilities | $11.9K | $9.6K | |
| Current Liabilities | $137.0K | $14.6K | |
| Capital Leases | $224.0K | · | |
| Total Liabilities | $361.0K | $14.6K | |
| Common Stock | $2.8K | $2.4K | |
| Retained Earnings | $-5M | $-622.4K | |
| Stockholders' Equity | $11M | $503.4K | |
| Liabilities + Equity | $12M | $517.9K | |
| Shares Outstanding | 28,340,812 | 24,000,000 |
Flusso di cassa 3
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Operating Cash Flow | $-10M | $-555.6K | |
| Stock Issued | · | $630.0K | |
| Financing Cash Flow | $15M | $630.1K |
Redditività 2
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| ROA | -69.8% | · | |
| ROE | -73.3% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 81.9 | · | |
| Quick Ratio | 36.5 | · |
Valutazione (TTM) 7
| Metrica | Tendenza | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-4M | · | |
| Market Cap | $9M | · | |
| P/E | -1.9 | · | |
| P/B | 0.8 | · | |
| P / Tangible Book | 0.8 | · | |
| P / Cash Flow | -0.9 | · | |
| Earnings Yield | -51.4% | · |
Conto Economico 10
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $677.5K | · | · | |
| SG&A Expense | $927.2K | $786.3K | $273.9K | $57.7K | $72.7K | |
| Operating Expenses | $3M | $3M | $951.3K | $57.7K | $147.4K | |
| Operating Income | $-3M | $-3M | $-951.3K | $-57.7K | $-147.4K | |
| Net Income | $-3M | $-3M | $-954.1K | $-60.3K | $-145.9K | |
| EPS (Basic) | $-0.11 | $-0.12 | $-0.04 | $0.00 | $0.02 | |
| EPS (Diluted) | $-0.11 | $-0.12 | $-0.04 | $0.00 | $0.02 | |
| Shares (Basic) | 28,344,545 | 958,244 | 25,599,673 | 24,000,000 | 9,059,016 | |
| Shares (Diluted) | 28,344,545 | 958,244 | 25,599,673 | 24,000,000 | 9,059,016 | |
| EBITDA | $-3M | · | $-951.3K | $-57.7K | · |
Stato Patrimoniale 15
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $6M | $108.9K | · | |
| Prepaid Expense | $4M | $6M | $9M | $6.3K | $1.2K | |
| Other Current Assets | · | · | · | $596.2K | $367.9K | |
| Current Assets | $8M | $11M | $14M | $711.3K | $517.9K | |
| Total Assets | $8M | $12M | $14M | $787.2K | $517.9K | |
| Accounts Payable | $8.4K | $2.4K | $114.5K | $269 | $5.0K | |
| Accrued Liabilities | $13.2K | $11.9K | $10.3K | $575 | $9.6K | |
| Current Liabilities | $128.7K | $137.0K | $186.0K | $75.9K | $14.6K | |
| Capital Leases | $203.9K | $224.0K | · | $5.8K | · | |
| Total Liabilities | $332.6K | $361.0K | $186.0K | $481.7K | $14.6K | |
| Common Stock | $2.8K | $2.8K | $2.8K | $2.4K | $2.4K | |
| Retained Earnings | $-8M | $-5M | $-2M | $-820.4K | $-622.4K | |
| Stockholders' Equity | $8M | $11M | $14M | $305.4K | $503.4K | |
| Liabilities + Equity | $8M | $12M | $14M | $787.2K | $517.9K | |
| Shares Outstanding | 28,364,812 | 28,340,812 | 28,340,812 | 24,000,000 | 24,000,000 |
Flusso di cassa 4
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $9.8K | · | · | · | · | |
| Operating Cash Flow | $-954.6K | $-857.4K | $-9M | $-290.1K | $-95.4K | |
| Stock Issued | · | · | · | · | $0 | |
| Financing Cash Flow | · | $0 | $15M | $200.0K | $0 |
Redditività 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| ROA | -74.9% | · | -13.2% | -15.3% | · | |
| ROE | -78.0% | · | -13.4% | -39.5% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Current Ratio | 62.9 | · | 77.5 | 9.4 | · | |
| Quick Ratio | 31.1 | · | 31.2 | 1.4 | · |
Valutazione (TTM) 7
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-4M | · | $-1M | $-333.3K | · | |
| Market Cap | $14M | · | $20M | · | · | |
| P/E | -3.2 | · | · | · | · | |
| P/B | 1.8 | · | 1.4 | · | · | |
| P / Tangible Book | 1.8 | · | 1.4 | · | · | |
| P / Cash Flow | -15.2 | · | · | · | · | |
| Earnings Yield | -31.3% | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Utile netto | $-4M | $-361.5K |
| EPS Diluito | $-0.17 | $-0.03 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Rapporto corrente | 81.9 | — |
| Quick Ratio | 36.5 | — |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.